GLAND PHARMA LTD (India) holds 69 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 40 active ingredients, holds 1 active Type IV (excipient) Drug Master File and is linked to 4 FDA-registered manufacturing sites. 31 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “GLAND PHARMA LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/gland-pharma-ltd

Overview

GLAND PHARMA LTD is an active pharmaceutical ingredient (API) supplier with 69 active FDA Type II Drug Master Files, covering ACETAZOLAMIDE; ARGATROBAN MONOHYDRATE (PROCESS-II); ARGATROBAN MONOHYDRATE USP; ARIPIPRAZOLE LAUROXIL – STERILE; ARIPIPRAZOLE MONOHYDRATE – STERILE; ATRACURIUM BESYLATE USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which GLAND PHARMA LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

GLAND PHARMA LTD holds 69 active (69 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • PRALATREXATEActive2025-09-29
  • ISAVUCONAZONIUM SULFATEActive2025-06-13
  • DANTROLENE SODIUMActive2024-03-29
  • LEVOCARNITINEActive2023-11-27
  • FOSAPREPITANT DIMEGLUMINEActive2023-09-29
  • EPINEPHRINE (LOW EPIMER)Active2023-09-27
  • MANGANESE SULFATEActive2022-12-30
  • CUPRIC SULFATEActive2022-12-23
  • LINEZOLIDActive2022-11-30
  • ACETAZOLAMIDEActive2022-10-31
  • CYSTEAMINE HYDROCHLORIDEActive2022-08-30
  • SELENIOUS ACIDActive2022-08-24
  • CHLOROTHIAZIDEActive2022-06-30
  • REGADENOSON (PROCESS – II)Active2022-06-24
  • PROTAMINE SULFATEActive2021-12-29
  • ARIPIPRAZOLE LAUROXIL – STERILEActive2021-12-22
  • PROCAINAMIDE HYDROCHLORIDEActive2021-10-30
  • ARIPIPRAZOLE MONOHYDRATE – STERILEActive2021-09-30
  • DIPHENHYDRAMINE HYDROCHLORIDEActive2021-06-30
  • NETARSUDIL DIMESYLATEActive2021-06-17
  • KETAMINE HYDROCHLORIDEActive2020-12-30
  • EPINEPHRINEActive2020-12-16
  • FOMEPIZOLEActive2020-11-30
  • EDARAVONEActive2020-08-20
  • ZINC SULFATE HEPTAHYDRATEActive2020-06-30
  • LACOSAMIDEActive2020-04-29
  • ERYTHROMYCIN LACTOBIONATEActive2019-12-31
  • CISATRACRIUM BESYLATEActive2019-12-26
  • TIGECYCLINE [PROCESS – II]Active2019-12-04
  • SUGAMMADEX SODIUMActive2019-10-31
  • ETOMIDATEActive2019-09-30
  • FLUPHENAZINE DECANOATEActive2019-05-31
  • FOSPHENYTOIN SODIUMActive2019-04-29
  • ISOPROTERENOL HYDROCHLORIDEActive2019-02-28
  • DOXYCYCLINE HYCLATE USPActive2018-09-28
  • GLATIRAMER ACETATEActive2018-09-12
  • ERTAPENEM SODIUMActive2018-01-12
  • NEOSTIGMINE METHYLSULFATEActive2017-10-31
  • PALIPERIDONE PALMITATE STERILEActive2017-10-13
  • CASPOFUNGIN ACETATEActive2017-07-21
  • PLERIXAFORActive2017-04-26
  • ZIPRASIDONE MESILATE TRIHYDRATEActive2016-09-30
  • BETAMETHASONE ACETATE USP STERILEActive2016-08-01
  • TIGECYCLINE [MANUFACTURING SITE - II]Active2015-09-30
  • FOSCARNET SODIUM USPActive2015-09-28
  • FULVESTRANT USPActive2015-09-28
  • CISATRACURIUM BESYLATE [PROCESS-II]Active2015-09-24
  • IRON SUCROSE COMPLEXActive2015-08-31
  • ATRACURIUM BESYLATE USP [PROCESS-II]Active2015-08-28
  • LEVOTHYROXINE SODIUM USPActive2015-07-27

Showing the 50 most relevant of 69 Drug Master Files (active first). The full list is in the FDA DMF list.

Excipient Drug Master Files

GLAND PHARMA LTD holds 1 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

Registered manufacturing sites (4)

Physical sites registered with the US FDA and resolved to GLAND PHARMA LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

31 FDA enforcement records linked to this company.

  • 4832024-07-25

    Procedures not in writing, fully followed

  • 4832024-07-25

    Record maintenance 1 year (except exempt OTC)

  • 4832023-07-14

    Complete test data included in records

  • 4832019-11-07

    Representative Samples

  • 4832019-11-07

    Scientifically sound laboratory controls

  • 4832019-11-07

    Written record of investigation incomplete

  • 4832019-11-07

    Equipment for Environmental Control

  • 4832019-11-01

    Written record of investigation incomplete

  • 4832019-11-01

    Validation lacking for sterile drug products

  • 4832019-05-16

    Written procedures lacking for use of pesticides etc.

  • 4832019-05-16

    Scientifically sound laboratory controls

  • 4832019-05-16

    Written procedures fail to include

  • 4832019-05-16

    Cleaning SOPs/schedules

  • 4832019-05-16

    Written record of investigation incomplete

  • 4832019-05-16

    Environmental Monitoring System

  • 4832019-05-16

    Product flow through building is inadequate

  • 4832018-02-23

    Training , Education , Experience overall

  • 4832018-02-23

    Procedures for sterile drug products

  • 4832018-02-23

    In-process conformity - examination, sample testing

  • 4832018-02-23

    Complaint Handling Procedure

  • 4832012-09-07

    Investigations of discrepancies, failures

  • 4832012-09-07

    Control procedures to monitor and validate performance

  • 4832012-09-07

    Training , Education , Experience overall

  • 4832012-09-07

    Contamination, chemical or physical change, deterioration

  • 4832012-09-07

    Complete test data included in records

  • 4832012-09-07

    Protective Apparel Not Worn

  • 4832012-09-07

    Calibration/Inspection/Checking not done

  • 4832012-09-07

    Written program not followed

  • 4832012-09-07

    Written sanitation procedures not followed

  • 4832012-09-07

    Drug products-sampling procedures/specifications

  • 4832012-09-07

    Procedures for sterile drug products

For suppliers

Is this GLAND PHARMA LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.